Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Liang

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Cancer Letters|December 15, 2018
Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathwaysYan-Lai Tang, Xi Sun, Li-Bin Huang, et al.
Pediatric Research|January 4, 2026
Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysisZhi-Yan Chen, Qiao-Ru Li, Liu-Hua Liao, et al.
Gut|December 25, 2025
Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinomaYasi Pan, Xiang Zhang, Chi Chun Wong, et al.
Recent Patents on Anti-Cancer Drug Discovery|December 12, 2022
Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic LeukemiaYan-Lai Tang, Jia-Yin Su, Jie-Si Luo, et al.
Annals of Hematology|October 15, 2025
Prognostic scoring model incorporating clinical characteristics for pediatric hemophagocytic lymphohistiocytosis: a multicenter retrospective studyShu-Yi Guo, Ru Tang, Shi-Lin Liu, et al.
Oncotarget|March 17, 2016
Development of a new outcome prediction model for Chinese patients with penile squamous cell carcinoma based on preoperative serum C-reactive protein, body mass index, and standard pathological risk factors: the TNCB score group systemZai-Shang Li, Peng Chen, Kai Yao, et al.
Nature Communications|January 22, 2024
LOX-1 acts as an N<sup>6</sup>-methyladenosine-regulated receptor for Helicobacter pylori by binding to the bacterial catalaseJudeng Zeng, Chuan Xie, Ziheng Huang, et al.
Cancer Cell|August 13, 2024
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkersYang Sun, Xiang Zhang, Dong Hang, et al.
Nature Metabolism|January 21, 2025
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axisXiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, et al.
Nature Metabolism|January 8, 2025
Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axisXiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Cancer Letters|December 15, 2018
Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathwaysYan-Lai Tang, Xi Sun, Li-Bin Huang, et al.
Pediatric Research|January 4, 2026
Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysisZhi-Yan Chen, Qiao-Ru Li, Liu-Hua Liao, et al.
Gut|December 25, 2025
Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinomaYasi Pan, Xiang Zhang, Chi Chun Wong, et al.
Recent Patents on Anti-Cancer Drug Discovery|December 12, 2022
Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic LeukemiaYan-Lai Tang, Jia-Yin Su, Jie-Si Luo, et al.
Annals of Hematology|October 15, 2025
Prognostic scoring model incorporating clinical characteristics for pediatric hemophagocytic lymphohistiocytosis: a multicenter retrospective studyShu-Yi Guo, Ru Tang, Shi-Lin Liu, et al.
Oncotarget|March 17, 2016
Development of a new outcome prediction model for Chinese patients with penile squamous cell carcinoma based on preoperative serum C-reactive protein, body mass index, and standard pathological risk factors: the TNCB score group systemZai-Shang Li, Peng Chen, Kai Yao, et al.
Nature Communications|January 22, 2024
LOX-1 acts as an N<sup>6</sup>-methyladenosine-regulated receptor for Helicobacter pylori by binding to the bacterial catalaseJudeng Zeng, Chuan Xie, Ziheng Huang, et al.
Cancer Cell|August 13, 2024
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkersYang Sun, Xiang Zhang, Dong Hang, et al.
Nature Metabolism|January 21, 2025
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axisXiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, et al.
Nature Metabolism|January 8, 2025
Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axisXiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, et al.
Pageof 20